Pierre Fenaux Selected Research

Hemorrhage

10/2023	Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS).
7/2022	Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study.
1/2021	Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
11/2019	Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.
3/2017	Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.
6/2014	Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia.
1/2010	Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia.
2/2009	Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
3/2003	Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Fenaux Research Topics

Disease

179	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2024 - 06/2001
68	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 12/2004
34	Neoplasms (Cancer) 12/2023 - 01/2004
25	Acute Promyelocytic Leukemia 01/2023 - 04/2002
23	Thrombocytopenia (Thrombopenia) 12/2023 - 03/2003
23	Leukemia 11/2023 - 02/2002
16	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 12/2023 - 09/2008
16	Anemia 12/2021 - 07/2004
15	Neutropenia 01/2024 - 01/2004
9	Hemorrhage 10/2023 - 03/2003
8	Infections 11/2023 - 12/2004
7	Febrile Neutropenia 12/2023 - 04/2016
7	Iron Overload 01/2023 - 12/2004
6	Disease Progression 12/2023 - 08/2010
6	VEXAS syndrome 07/2023 - 11/2021
5	Cytopenia 11/2023 - 04/2010
4	Pneumonia (Pneumonitis) 12/2023 - 04/2016
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 03/2003
4	Chromosome Aberrations (Chromosome Abnormalities) 01/2012 - 06/2001
4	Polycythemia Vera 11/2010 - 06/2006
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2004 - 04/2002
3	Hematologic Neoplasms (Hematological Malignancy) 05/2024 - 03/2008
3	Leukopenia 12/2023 - 01/2004
3	Fatigue 01/2023 - 01/2018
3	Nausea 01/2023 - 01/2020
3	Vasculitis (Vasculitides) 10/2020 - 04/2012
3	Primary Myelofibrosis (Myelosclerosis) 01/2019 - 11/2010
3	Lymphoma (Lymphomas) 01/2018 - 09/2002
3	Chromosome 5q Deletion Syndrome 07/2013 - 01/2006
3	Refractory Anemia with Excess of Blasts (RAEM) 12/2010 - 04/2010
2	Body Weight (Weight, Body) 01/2023 - 01/2020
2	Asthenia 01/2023 - 01/2020
2	Diarrhea 01/2020 - 12/2018

Drug/Important Bio-Agent (IBA)

63	Azacitidine (5 Azacytidine)FDA Link 12/2023 - 12/2005
40	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2006
20	HematinicsIBA 04/2024 - 03/2009
19	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2024 - 01/2004
15	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021 - 05/2005
12	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2004
11	Arsenic Trioxide (Trisenox)FDA Link 12/2021 - 04/2002
10	AnthracyclinesIBA 12/2018 - 06/2006
8	Decitabine FDA Link 12/2023 - 12/2005
8	luspaterceptIBA 11/2023 - 01/2019
8	Erythropoietin FDA Link 01/2022 - 07/2004
7	romiplostim FDA Link 10/2022 - 01/2010
7	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2014 - 02/2008
6	Biomarkers (Surrogate Marker)IBA 10/2022 - 07/2017
6	IronIBA 01/2020 - 07/2010
6	DNA (Deoxyribonucleic Acid)IBA 06/2017 - 04/2005
6	ErbB Receptors (EGF Receptor)IBA 12/2014 - 02/2008
5	eltrombopag FDA Link 10/2023 - 03/2017
5	SteroidsIBA 11/2022 - 03/2003
4	venetoclaxIBA 03/2024 - 01/2020
4	guadecitabineIBA 01/2024 - 01/2019
4	EnzymesIBA 07/2023 - 12/2017
4	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2023 - 01/2004
4	Inosine Triphosphate (ITP)IBA 01/2021 - 03/2003
4	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2015 - 01/2004
4	Gefitinib (Iressa)FDA Link 09/2013 - 12/2008
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2008 - 07/2004
3	imetelstatIBA 04/2024 - 01/2021
3	Daunorubicin (Cerubidine)FDA LinkGeneric 07/2023 - 02/2010
3	RG7388IBA 01/2023 - 05/2020
3	Hemoglobins (Hemoglobin)IBA 11/2021 - 07/2013
3	Interleukin-2 (IL2)IBA 01/2021 - 03/2008
3	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 12/2018 - 02/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017 - 12/2013
3	Rituximab (Mabthera)FDA Link 09/2017 - 08/2008
3	MethyltransferasesIBA 06/2017 - 12/2005
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2014 - 12/2004
3	Farnesyltranstransferase (Farnesyltransferase)IBA 05/2008 - 05/2007
2	RNA Splicing FactorsIBA 04/2024 - 03/2013
2	olutasidenibIBA 03/2024 - 07/2023
2	CPX-351IBA 11/2023 - 07/2023
2	UbiquitinIBA 07/2023 - 01/2022
2	Codon (Codons)IBA 04/2023 - 12/2009
2	Retinoic Acid Receptor alphaIBA 01/2023 - 10/2015
2	Messenger RNA (mRNA)IBA 01/2023 - 01/2023
2	eprenetapoptIBA 10/2021 - 10/2021
2	InflammasomesIBA 01/2021 - 09/2018
2	Ferritins (Ferritin)IBA 01/2019 - 09/2012
2	ArsenicIBA 12/2018 - 01/2018
2	Vorinostat FDA Link 01/2018 - 01/2014

Therapy/Procedure

52	Therapeutics 05/2024 - 04/2002
31	Drug Therapy (Chemotherapy) 01/2024 - 06/2001
18	Erythrocyte Transfusion 04/2024 - 12/2004
12	Stem Cell Transplantation 05/2024 - 10/2002
8	Hematopoietic Stem Cell Transplantation 05/2024 - 12/2005
7	Induction Chemotherapy 12/2023 - 06/2007
5	Aftercare (After-Treatment) 01/2020 - 04/2005
4	Chelation Therapy (Therapy, Chelation) 01/2020 - 07/2010
3	Drug Tapering 10/2021 - 05/2008
3	Salvage Therapy 11/2019 - 02/2009
3	Platelet Transfusion (Blood Platelet Transfusions) 03/2018 - 01/2010
3	Radiotherapy 06/2014 - 06/2001
2	Transplantation 12/2023 - 01/2017
2	Homologous Transplantation 01/2023 - 01/2022
2	Cell Transplantation 01/2022 - 09/2012
2	Precision Medicine 09/2021 - 05/2015
2	Consolidation Chemotherapy 12/2018 - 09/2003